A congressional panel focused on China urged federal agencies to consider banning Chinese doctors and institutions linked to what it called the “heinous practice” of forced organ harvesting. The House committee said the latest ETAC report and other recent investigative findings “justifiably renewed serious concerns about the heinous practice of forced organ harvesting in China with allegations of violations of internationally recognized standards for organ procurement and informed consent,” according to a post on X. “These findings underscore the need for continued scrutiny of transplant institutions, medical personnel, and affiliated entities in China that may be involved in facilitating, concealing, or misrepresenting unethical transplantation practices.” The House committee is chaired by Rep. John Moolenaar (R-Mich.), with Rep. Ro Khanna (D-Calif.) as its ranking member. To “strengthen accountability and transparency,” the House committee urged federal agencies to consider compiling a list of “Chinese individuals, hospitals, research institutes, professional associations, and other entities credibly linked to organ transplant abuses or efforts to obscure such activities.” “[Such a list would] restrict their access to the United States, U.S. medical institutions, research partnerships, training programs, and other forms of cooperation until these concerns have been addressed in a meaningful way,” the House committee said. Of the 71 papers identified in the 2022 study, three-quarters were published after 1999, the year when the CCP launched a persecution campaign to eradicate Falun Gong, a spiritual practice centered on the teachings of truthfulness, compassion, and forbearance. The latest report “provides detailed information on Chinese hospitals and doctors linked to abuses that can be used for government and U.S. institutional vetting,” the group said. ETAC also urged Congress to pass the Falun Gong and Victims of Forced Organ Harvesting Protection Act (S. 4009) and the Stop Forced Organ Harvesting Act (H.R. 1503), saying that the legislation would “reduce impunity in China and increase transparency on collaborations with U.S. institutions.” A key provision of the Senate bill would sanction foreign individuals for carrying out or facilitating forced organ harvesting, barring them from entering the United States. Another provision directs the State Department to investigate transplant policies and practices in China, in consultation with other agencies, including the Department of Health and Human Services and the National Institutes of Health.